| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |